CROs (contract research organisations) have been an integral part of the drug development landscape since they emerged in the 1970s. Read our article to learn how their role has evolved over the last several decades, and how they partner with the industry to deliver innovation.
For our latest virtual breakfast briefing, PharmaMedic Managing Director Dr Malcolm Barratt-Johnson discussed with guest speakers Dr Nelson Kinnersley and Dr Alexander Schacht – both seasoned statistical leaders- how partnering with your statistician can add value throughout the product life cycle. If you missed it, read on for a summary of key takeaways and to access a recording of the event.
In this article, we'll discuss recent developments in various applications of digital healthcare and the advances that we expect to see on the horizon. Find out more.
Last year, our colleague Dr Zubair Hussain, Chairman of LE4D Global Regulatory and a PharmaMedic partner, provided an insightful strategic update on critical regulatory trends at PharmaMedic's inaugural virtual breakfast briefing. In this new article, we sat down with Dr Hussain once again to learn his latest insights on the three key issues he tips for the top of the regulatory agenda over the coming months. Read on to find out more.
PharmaMedic is delighted to announce our next virtual event on Wednesday 29th June 2022 at 8 am (GMT). In this briefing, we will be discussing the integral role that statisticians, and innovative statistical approaches play in enabling medical, clinical, and commercial teams to make better development decisions, conduct more efficient research, and ensure more successful commercialisation. We are delighted to welcome as speakers two seasoned statistical leaders, Nelson Kinnersley, Founder and Director at Octa Consulting Services Ltd, and Alexander Schacht, Executive VP Launch and Commercialisation Data Science at Veramed. Read on to learn more, and to register your attendance.
We enjoyed our first joint webinar with PharmaMedic and Triducive of 2022. Our guest speakers, Dr Malcolm Barratt-Johnson (PharmaMedic) and Tim Warren (Triducive) joined Nick Williams (Triducive) for a discussion and interactive Q&A on the evolving and increasingly strategic role of medical affairs within pharma and life sciences businesses. Read on for the key takeaways.
In the UK, we now seem to be moving into a new phase of pandemic management, with the government aiming to” transition to managing COVID-19 like other respiratory illnesses”. In their recent March 2022 statement, the government attributes this evolution in approach to vaccines and treatments. In this short article, we overview the current role of antivirals and monoclonal antibodies and look ahead to future developments in our attempt to manage the day-to day risks of living with COVID-19.
Join Triducive and PharmaMedic for an interactive webinar on Thursday 28th April at 8.00AM. Keynote speakers Dr Malcolm Barratt-Johnson and Tim Warren will be discussing the strategic role of medical affairs in Pharma and the potential role of Delphi based studies for strategic impact. Find out more.
Non-Executive Directors play an integral role for any organisation, not least within the life science space where leadership often needs to draw on a broad range of strategic and tactical expertise to drive the business forward. In this short Q&A article, we interview PharmaMedic Managing Director Dr Malcolm Barratt-Johnson about the value that a pharmaceutical physician delivers in the role of NED.
We enjoyed our first virtual breakfast briefing of 2022, with a new lively panel discussion format. Our guest panelists, Dr Lucy Cook (PharmaMedic consultant and Director of Wiltshire Pharma), Mr Guy Francis (UK Marketing Director, Amarin UK) and Mr Andy Wise (Managing Pharma Consultant, Blue Pelican) joined Dr Malcolm Barratt-Johnson to discuss key themes set to shape medical affairs in 2022. Read on for a summary of key takeaways and to access our recording of the event.
